UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063225
Receipt number R000072367
Scientific Title An Exploratory Study on Longitudinal Changes in Urinary IgA Concentrations Among Junior High School Students During the High School Entrance Examination Period
Date of disclosure of the study information 2026/10/13
Last modified on 2026/10/08 21:48:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An Exploratory Study on Longitudinal Changes in Urinary IgA Concentrations Among Junior High School Students During the High School Entrance Examination Period

Acronym

An Exploratory Study on Longitudinal Changes in Urinary IgA Concentrations Among Junior High School Students During the High School Entrance Examination Period

Scientific Title

An Exploratory Study on Longitudinal Changes in Urinary IgA Concentrations Among Junior High School Students During the High School Entrance Examination Period

Scientific Title:Acronym

An Exploratory Study on Longitudinal Changes in Urinary IgA Concentrations Among Junior High School Students During the High School Entrance Examination Period

Region

Japan


Condition

Condition

immunity

Classification by specialty

Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

uring the entrance examination preparation period, major health management challenges for students include irregular lifestyle habits-such as chronic sleep deprivation, physical inactivity, and nutritional imbalances-as well as psychological burdens, including severe stress and anxiety. These factors often lead to physical and mental distress, accompanied by an increased risk of infectious diseases. Consequently, they can impair students' daily school life and undermine their physical and cognitive performance on examination days.
Although various approaches have been explored to address these issues, few studies have addressed them from an immunological perspective. Immune status is likely linked both to upstream factors, such as lifestyle habits and psychological stress, and to downstream outcomes, such as infection risk. Therefore, quantifying individual immune status could serve a dual purpose: enabling students to evaluate the efficacy of lifestyle modifications and stress-reduction strategies, while fostering heightened awareness regarding infection prevention. This approach has the potential to contribute meaningfully to resolving the aforementioned challenges. As a critical first step, this study aims to assess longitudinal changes and fluctuations in immune status among students throughout the examination preparation period.

Basic objectives2

Bio-equivalence

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Longitudinal changes in urinary IgA concentrations (creatinine-corrected value: IgA/creatinine ratio)
this study measures urinary renalase, cytokines (IL-6 and IL-8), titin N-terminal fragment, myoglobin, cell-free DNA (cfDNA), cell-free RNA (cfRNA)-both restricted to fragment size measurement and quantification without sequence identification-and the indole test as a gut microbiota marker, to examine their associations with daily physical activity levels.
(Time points: Assessed at four time points across the study period [late October-early November, early-mid December, early-mid January, and mid-late February])

Key secondary outcomes

Dietary habits (breakfast habits, balanced meals combining staple food, main dish, and side dishes, protein intake, frequency of consuming sweets and sugary drinks), sleep (duration, quality, feeling of recovery from sleep), physical activity (habit of exercising for >=30 minutes, exercise on holidays, sedentary time), psychological well-being (WHO-5 Well-Being Index), stress (Perceived Stress Scale: PSS-4), health status (presence or absence of cold-like symptoms, school absenteeism), immune-care behaviors (presence or absence, selection of specific behaviors), history of events related to entrance examinations (mock exams, school exams, interviews, etc.)
(Time points: Assessed at four time points across the study period [late October-early November, early-mid December, early-mid January, and mid-late February])


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

13 years-old <

Age-upper limit

15 years-old >=

Gender

Male and Female

Key inclusion criteria

This study will be conducted with second- and third-year students from our university-affiliated junior high schools. The eligibility criteria for participation are as follows:
Second- or third-year male and female students enrolled at the Yokohama Junior High School or Kamakura Junior High School affiliated with Yokohama National University.
Students whose parents or legal guardians have received a comprehensive explanation regarding the purpose and procedures of this study and have provided written informed consent for their child's participation.
Students who received an explanation using an assent document and voluntarily agreed to participate.

Key exclusion criteria

This study will be conducted with second- and third-year students from our university-affiliated junior high schools. The exclusion criteria for participation are as follows:
Students who are unable to collect their own urine samples using the designated procedure.
Students who have an autoimmune disease and are currently undergoing medical treatment or pharmacotherapy.
Students who have kidney disease or renal dysfunction and are currently undergoing medical treatment or pharmacotherapy.
Any other students deemed unsuitable for participation by the principal investigator.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Katsuyuki
Middle name
Last name Tokinoya

Organization

Yokohama National University

Division name

College of Education

Zip code

240-8501

Address

79-2 Tokiwadai, Hodogaya-ku, Yokohama, Kanagawa

TEL

0453393277

Email

tokinoya-katsuyuki-ys@ynu.ac.jp


Public contact

Name of contact person

1st name Katsuyuki
Middle name
Last name Tokinoya

Organization

Yokohama National University

Division name

College of Education

Zip code

240-8501

Address

79-2 Tokiwadai, Hodogaya-ku, Yokohama, Kanagawa

TEL

0453393277

Homepage URL


Email

tokinoya-katsuyuki-ys@ynu.ac.jp


Sponsor or person

Institute

Yokohama National University

Institute

Department

Personal name



Funding Source

Organization

Kirin Holdings Company, Limited.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Kirin Health Sciences Institute, Kanagawa Technology Innovations Inc.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yokohama National University

Address

Yokohama National University

Tel

0453393075

Email

kenkyu.somu@ynu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 10 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 10 Month 13 Day

Date of IRB

2026 Year 10 Month 07 Day

Anticipated trial start date

2026 Year 10 Month 13 Day

Last follow-up date

2029 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study aims to continuously monitor the immune status of junior high school students preparing for entrance examinations to clarify its chronological changes, as well as to investigate its associations with lifestyle habits, subjective health status, and the onset of infectious diseases. Furthermore, this study will exploratorily evaluate whether providing feedback on the measurement results to the students leads to improvements in lifestyle habits and the implementation of infection prevention behaviors.


Management information

Registered date

2026 Year 10 Month 08 Day

Last modified on

2026 Year 10 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072367